Chronic TBI: A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury

Sponsor
The University of Texas Health Science Center, Houston (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT01171131
Collaborator
(none)
96
1
172
0.6

Study Details

Study Description

Brief Summary

The aim of this research is to determine if the biological fluids (blood/saliva) from chronic brain-injured patients (both blast and non-penetrating TBI) contain reproducible protein markers. To accomplish this two populations of chronic TBI patients who are receiving treatment at The Institute for Research and Rehabilitation (TIRR): blast injury victims and non-penetrating TBI will be studied. Using multiple proteomic approaches including mass spectrometry, multiplex ELISAs, and antibody microarrays, as well as RNA profiling, the investigators aim to identify biomarkers in the blood/saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups. Identification of these biochemical changes will give insight into the long-lasting changes associated with head injury, and may identify new targets for treating the associated pathologies.

Condition or Disease Intervention/Treatment Phase
  • Other: Blood/saliva sampling

Study Design

Study Type:
Observational
Actual Enrollment :
96 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
A Pilot Study to Identify Biomarkers Associated With Chronic TBI
Study Start Date :
Apr 1, 2010
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Chronic TBI Patients - Non-penetrating

Chronic TBI patients should have a history of head trauma manifesting in one or more of the following: Loss of consciousness Post-traumatic amnesia Focal neurologic deficits, seizure Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance) Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.) Patients will be excluded from the study if we are unable to obtain informed consent and if they are non-communicative (i.e. in a vegetative state).

Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)

Chronic TBI Patients - Blast

Chronic TBI Blast injury patients should have a history of head trauma manifesting in one or more of the following: Loss of consciousness Post-traumatic amnesia Focal neurologic deficits, seizure Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance) Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.) Patients will be excluded from the study if we are unable to obtain informed consent and if they are non-communicative (i.e. in a vegetative state).

Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)

Healthy Volunteers

Healthy volunteers include gender, age and race matched volunteers able to provide informed consent who have, No significant medical history Take no medications (other than birth control pills) Fever free No history of head trauma or recent injury/infection No history of neurological or psychiatric disorders or alcohol or drug dependency.

Other: Blood/saliva sampling
one-time blood sample (~ 1 TBS) and saliva sample (~ 1 tsp)

Outcome Measures

Primary Outcome Measures

  1. Proteomic analysis of plasma [average of 6 months post injury]

    The aim is to identify biomarkers in the blood of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.

Secondary Outcome Measures

  1. Proteomic analysis of saliva [average of 6 months post injury]

    The aim is to identify biomarkers in the saliva of patients suffering from chronic TBI and to determine the similarities/differences between the blast and non-penetrating injury groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Chronic TBI patients:

Inclusion Criteria

Have a history of head trauma manifesting in one or more of the following:
  • Loss of consciousness

  • Post-traumatic amnesia

  • Focal neurologic deficits, seizure

  • Persistent symptoms of increased arousal (e.g. difficulty falling or staying asleep, anger and hypervigilance)

  • Impairment in social, occupational, or other important areas of functioning (e.g. problems with work and relationships.)

Exclusion Criteria

Inability to obtain informed consent and if they are non-communicative (i.e. in a vegetative state).

Healthy volunteers:

Inclusion Criteria

  • No significant medical history

  • Take no medications (other than birth control pills)

  • Fever free

  • No history of head trauma or recent injury/infection

  • No history of neurological or psychiatric disorders or alcohol or drug dependency.

Exclusion Criteria

  • Inability to provide informed consent

  • age/gender match not available in TBI cohort

Contacts and Locations

Locations

Site City State Country Postal Code
1 TIRR Houston Texas United States 77030

Sponsors and Collaborators

  • The University of Texas Health Science Center, Houston

Investigators

  • Principal Investigator: Georgene Hergenroeder, PhD, The University of Texas Health Science Center, Houston

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Georgene Hergenroeder, Associate Professor, Neurosurgery, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT01171131
Other Study ID Numbers:
  • HSC-MS-09-0334
First Posted:
Jul 28, 2010
Last Update Posted:
Sep 8, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Georgene Hergenroeder, Associate Professor, Neurosurgery, The University of Texas Health Science Center, Houston
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 8, 2021